Description: Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It focuses on the development of yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people; and IsoPet for animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 is headquartered in Richland, Washington.
Home Page: www.radiogel.com
719 Jadwin Avenue
Richland,
WA
99352
United States
Phone:
509 736 4000
Officers
| Name | Title |
|---|---|
| Dr. Michael K. Korenko Ph.D. | CEO, Pres & Director |
| Dr. Carlton M. Cadwell D.D.S. | Independent Chairman & Sec. |
| Mr. Michael H. Pollack CPA, CPA | Chief Financial Officer |
| Dr. David J. Swanberg M.S., P.E. | Chief Technical Mang. |
| Dr. Nigel R. Stevenson B.Sc., Ph.D. | Chief Science Officer |
| Dr. Fu-Min Su | Chief Radio Chemist & Radiation Safety Officer |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.0062 |
| Price-to-Sales TTM: | 598.6187 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1 |